Latest Manufacturing Scale Up News

The Calmer Co. has secured a long-term supply agreement for premium noble kava from Papua New Guinea and Vanuatu, underpinning its manufacturing growth and diversified Pacific sourcing network.

Advanced Innergy Holdings (ASX:AIH) has revised down its FY26 revenue and EBITDA forecasts due to project timing delays and supply chain issues but maintains a robust order book and financial position.

Structural Monitoring Systems Plc (ASX: SMN) reported a milestone FY26 with record revenue of $32.5 million and net profit rising to $1.2 million, driven by strong avionics growth and progressing FAA certification for its CVMTM smart sensor technology.

BLS Pharmaceuticals capped FY26 with record revenue and EBITDA, boosted by international expansion and major contracts, setting the stage for further growth in FY27.

AnteoTech has secured independent validation for its Ultranode™ 95 silicon anode in commercial drone battery cells, launched a new battery additive, and strengthened its cash position with a A$10 million capital raise.

Mesoblast has completed treatment of 300 patients in its pivotal Phase 3 trial for rexlemestrocel-L, targeting chronic low back pain due to degenerative disc disease, with topline results expected mid-2027.

Mayfield Group Holdings is set to acquire Nilsen's Switchboards Division for $4 million, adding 66 skilled employees and the N-Series product platform to boost manufacturing capacity and revenue.

AnteoTech has shipped a 20-litre sample of its new Anteo C primer coating additive to a South Korean manufacturer, marking a key step from lab trials to manufacturing-scale evaluation in lithium-ion battery production.

GCM Corporation has inked a binding 24-month joint development agreement with Shenzhen Wanwei Heat Conduction Technology (ALVC) to co-develop a hybrid thermal management product combining vapour chamber and VHD heat sink technologies.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

Boresight Ltd (ASX: BST) is seeking to raise $8 million through a public offer to expand its cost-effective military drone manufacturing, targeting growth in the US and European markets.

Rhythm Biosciences marked a pivotal shift from development to commercial diagnostics in Q3 FY26, recording its first ColoSTAT® clinical sale and initiating NHS England evaluation while expanding geneType™ partnerships across Asia and Australia.